Clinical trial

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

NCT01881763

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE4

Study timeline

Study start (actual)2010-06-01Date precision: month

Registry last updated2023-03-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Unipolar Depressionverified · MONDO: major depressive disorder

Bipolar Depressionverified · MONDO: bipolar depression

Interventions

KetamineDRUG · verified · RxNorm: ketamine

MethohexitalDRUG · verified · RxNorm: methohexital

Sponsors & collaborators

Northwell Healthlead sponsor

National Alliance for Research on Schizophrenia and Depressioncollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01881763 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.